Drug profile · INN
dronedarone hydrochloride
DRONEDARONE HYDROCHLORIDE
dronedarone hydrochloride (DRONEDARONE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — dronedarone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dronedarone hydrochloride (DRONEDARONE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Inward rectifier potassium channel 2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is dronedarone hydrochloride?
dronedarone hydrochloride (DRONEDARONE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dronedarone hydrochloride?
DRONEDARONE HYDROCHLORIDE is a marketed brand name for dronedarone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dronedarone hydrochloride?
dronedarone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.